SIMVASTATINE MYLAN 10 mg, film-coated tablet 28 tablets, CIP 3400930221532
Active ingredients: Simvastatin
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet28 tablets, CIP 3400930221532orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SIMVASTATINE MYLAN 10 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 28 comprimé(s)
- Marketing authorisation holder
- MYLAN SAS
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 22 Sept 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60512336CIP73022153CIP133400930221532Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SIMVASTATINEcomprimé | 10,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.